Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.47 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.46 |
| ▸ | CCNC | P24863 | 1/20 | 0.46 |
| ▸ | CDKN1A | P38936 | 1/20 | 0.46 |
| ▸ | CDK8 | P49336 | 1/20 | 0.46 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 9/20 | 0.46 |
| ▸ | LMNA | P02545 | 8/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 9/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 8/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.44 |
| ▸ | USP2 | O75604 | 7/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4173540 | 0.90 | IRAK4 (0.49) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4187778 | 0.90 | DYRK1A (0.47) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4181108 | 0.88 | IRAK4 (0.47) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4180580 | 0.87 | HDAC8 (0.47) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4172216 | 0.87 | CLK4 (0.62) | MAPK1LMNACYP1A2CYP3A4ALDH1A1 | |
| SCHEMBL4181447 | 0.86 | CLK4 (0.44) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4183706 | 0.85 | LMNA (0.43) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4170307 | 0.84 | CLK4 (0.51) | DYRK1AIRAK4MAPK1LMNAEGFR | |
| SCHEMBL4177922 | 0.84 | PIK3CD (0.48) | DYRK1AIRAK4CCNCCDKN1ACDK8 | |
| SCHEMBL4184127 | 0.83 | DYRK1A (0.47) | DYRK1AIRAK4CCNCCDKN1ACDK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | claimed |
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRM1, GRIN1, GRM2 | DYRK1A 3582/4885IRAK4 864/4885CCNC 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.